AZITROX 500 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

azitrox 500 mg

zentiva, k.s. - republica ceha - azithromycinum - compr. film. - 500mg - macrolide, lincosamide si streptogramine macrolide

DOCETAXEL DR REDDY'S 20 mg/1 ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

docetaxel dr reddy's 20 mg/1 ml

dr. reddy's laboratories romania s.r.l. - docetaxelum - conc. pt. sol. perf. - 20mg/1ml - alcaloizi din plante si alte produse naturale taxani

DOCETAXEL DR REDDY'S 80 mg/4 ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

docetaxel dr reddy's 80 mg/4 ml

dr. reddy's laboratories romania s.r.l. - docetaxelum - conc. pt. sol. perf. - 80mg/4ml - alcaloizi din plante si alte produse naturale taxani

ACID IBANDRONIC AUROBINDO 150 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

acid ibandronic aurobindo 150 mg

apl swift services (malta) limited - malta - acid ibandronicum - compr. film. - 150mg - med. ce influenteaza in structura osoasa si mineralizare bifosfonati

AZIBIOT 20 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

azibiot 20 mg/ml

krka, d.d., novo mesto - slovenia - azithromycinum - pulb. pt. susp. orala - 20mg/ml - macrolide, lincosamide si streptogramine macrolide

AZIBIOT 40 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

azibiot 40 mg/ml

krka, d.d., novo mesto - slovenia - azithromycinum - pulb. pt. susp. orala - 40mg/ml - macrolide, lincosamide si streptogramine macrolide

Riximyo Uniunea Europeană - română - EMA (European Medicines Agency)

riximyo

sandoz gmbh - rituximab - lymphoma, non-hodgkin; arthritis, rheumatoid; microscopic polyangiitis; wegener granulomatosis - agenți antineoplazici - riximyo is indicated in adults for the following indications:non-hodgkin’s lymphoma (nhl)riximyo is indicated for the treatment of previously untreated adult patients with stage iii-iv follicular lymphoma in combination with chemotherapy. riximyo maintenance therapy is indicated for the treatment of adult follicular lymphoma patients responding to induction therapy. riximyo monotherapy is indicated for treatment of adult patients with stage iii-iv follicular lymphoma who are chemoresistant or are in their second or subsequent relapse after chemotherapy. riximyo is indicated for the treatment of adult patients with cd20 positive diffuse large b cell non-hodgkin’s lymphoma in combination with chop (cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy. riximyo in combination with chemotherapy is indicated for the treatment of paediatric patients (aged ≥ 6 months to < 18 years old) with previously untreated advanced stage cd20 positive diffuse large b-cell lymphoma (dlbcl), burkitt lymphoma (bl)/burkitt leukaemia (mature b-cell acute leukaemia) (bal) or burkitt-like lymphoma (bll). chronic lymphocytic leukaemia (cll)riximyo in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. sunt disponibile doar date limitate privind eficacitatea și siguranța pentru pacienții tratați anterior cu anticorpi monoclonali inclusiv rituximab sau pacienții refractari la anterior cu rituximab plus chimioterapie. a se vedea secțiunea 5. 1 pentru informații suplimentare. rheumatoid arthritisriximyo in combination with methotrexate is indicated for the treatment of adult patients with severe active rheumatoid arthritis who have had an inadequate response or intolerance to other disease-modifying anti-rheumatic drugs (dmard) including one or more tumour necrosis factor (tnf) inhibitor therapies. rituximab a fost demonstrat de a reduce rata progresiei distrucției articulare prin x-ray și de a îmbunătăți funcția fizică, atunci când este administrat în asociere cu metotrexat. granulomatosis with polyangiitis and microscopic polyangiitisriximyo, in combination with glucocorticoids, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (wegener’s) (gpa) and microscopic polyangiitis (mpa). riximyo, in combination with glucocorticoids, is indicated for the induction of remission in paediatric patients (aged ≥ 2 to < 18 years old) with severe, active gpa (wegener’s) and mpa. pemphigus vulgarisriximyo is indicated for the treatment of patients with moderate to severe pemphigus vulgaris (pv).

Azithromycin Lek 500 mg comprimate filmate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

azithromycin lek 500 mg comprimate filmate

lek pharmaceuticals d.d. - azithromycinum - comprimate filmate - 500 mg

Azithromycin Lek 200 mg/5ml pulbere pentru suspensie orală Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

azithromycin lek 200 mg/5ml pulbere pentru suspensie orală

lek pharmaceuticals d.d. - azithromycinum - pulbere pentru suspensie orală - 200 mg/5ml

Azitrox 500 500 mg comprimate filmate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

azitrox 500 500 mg comprimate filmate

zentiva k.s. - azithromycinum - comprimate filmate - 500 mg